75% VC Misses Post-Conflict Opportunity 2026
75% of VC overlooks post-conflict regions. Why these areas offer outsized returns, faster profitability, and key social impact. Learn what's next.
75% of VC overlooks post-conflict regions. Why these areas offer outsized returns, faster profitability, and key social impact. Learn what's next.
BioGen Innovations raised $25M Series A for gene editing. See how biotech startups get funded and what investors look for next.
AI pharma investment reached $15B in 2025. See why this rapid growth matters for new drug development and what to watch next.
AgriGenix's 2026 challenge: Why do promising agrobio startups struggle for funding? Learn how to bridge the VC gap for sustainable agriculture.
S&P Global forecasts 2026 startup funding. Learn why investors prioritize profit, not hyper-growth, and how $75B targets AI.
TOYO invests $500M in solar suppliers. Will this boost production 30% by 2027 and secure market leadership? See what's next for solar.
2026's inverted yield curve impacts startups. Learn how to conserve cash, attract investors, and find M&A opportunities in a tough market.
Ocean tech funding surged to $3.5B in 2025. See why marine inventory startups attract early-stage capital and Asia-Pacific leads investment.
Biotech funding is shifting $3.4B to public health. Learn why current models fail societal needs and what BARDA's increased investment means.
Startup funding is drying up. Learn why PPI pressures are hitting capital raising, how valuations dropped 25%, and what founders must do now.